Summary.-The surviving fraction (SF) of Chinese hamster cells and HeLa cells after treatment with a range of Adriamycin concentrations and exposure times was determined. The cytostatic effect was proportional to the product of extracellular drug concentration (c) and exposure time (t) according to the equation: SF=e-ktc. By determining the intracellular drug concentration at various exposures, it could be shown that absorbed dose is not proportional to exposure dose.
ADRIAMYCIN is a potent drug in a variety of neoplastic diseases (Carter, 1975) . Although a number of empirical dosage schedules are used in the treatment with Adriamycin (Carter et al., 1972) , there is controversy about optimum schedule and dosage. Benjamin et al. (1974) correlating clinical and pharmacological observations proposed the intermittent single high-dose application of Adriamycin, suggesting that its effectiveness appeared to be related to schedule, rather than dose.
Treatment of leukaemia L1210 in the early stages seemed to have no definite schedule dependency (Goldin & Johnson, 1975) . The clinical studies of Creasy et al. (1976) suggested that Adriamycin given at short intervals caused greater toxicity than widely spaced doses. Pacciarini et al. (1978) presented experimental data demonstrating the superiority of the repeated schedule over the single highdose treatment. Although there was similar anti-tumour activity, survival increased and drug concentration was markedly lower in the heart than in the closely spaced schedule.
Skipper et al. (1970) studied optimal dose schedules for the treatment of L1210 leukaemia. They allotted all the cytostatic agents to 3 different tentative classes and showed that each class had a different optimal schedule. Daunomycin, which in its action is comparable to Adriamycin (Di Marco, 1975) belonged to the class of cycle-phase nonspecific drugs all of which over a wide range of administered dose have a concentration-dependent rate of cell kill. For these agents, he assumed the effect to be a function of the product of concentration and time. In the present study we will describe experiments on the dependence of cell survival of 2 different cell lines and Adriamycin concentration and exposure time. These studies are preliminary to in vivo experiments to be published elsewhere.
MATERIALS AND METHODS
Cell cultures.-Experiments were carried out with the following cell lines: B14F28 Chinese hamster cells, a lung fibroblast line (Born 1974 ) with an average cell-cycle time of 11-14 h and HeLa S3 cells, supplied by Flow Laboratories, Irvine, Scotland, and adapted to our culture conditions (mean cellcycle time 24 h). Monolayer cultures of both cell lines were cultured in Eagle's minimum essential medium (MEM) supplemented with 10% calf serum, 0 01 % neomycin and 0.035% NaHCO3. They were kept in a humidified CO2 incubator at pH 7-2 and 37°C (Eichholtz & Trott, 1980 Schwartz (1973) , using a Zeiss Fluorimeter. At the end of Adriamycin exposure, the cells were cooled immediately to 4°C, centrifuged, washed with Hanks' solution and centrifuged again. The cell sediment was resuspended in 1 ml MEM and added to 0-2 ml AgNO3 (33% w/v). After vigorous shaking for 10 min, the cells were extracted with 3-0 ml iso-amyl alcohol, shaken again for 10 min and then centrifuged (1000 g for 5 min at20°C). (Fig. 7) .
DISCUSSION
The results demonstrate that the surviving fraction of both cell lines is an exponential function of Adriamycin concentration in the medium and exposure time in the range tested (Figs 1-4) . The linear regression gives excellent fits to the nLool experimental data (r2 > 0.90). Skipper et al. (1970) Exponential survival curves were also found for CHO cells (Barranco, etal., 1973) , T1 cells (Drewinko & Gottlieb, 1973) and EMT6 cells (Twentyman, 1976) . However, at drug concentrations above 2 ,ug/ml the slopes of C01O and EMT6 cells decrease at surviving fractions of less than 0-002, yielding a biphasic ("hockey stick") curve. Our method does not allow the accurate determination of SFs less than 10-3, and thus a similar biphasic response cannot be excluded. (1978) have demonstrated that exposure dose, defined as the product of drug concentration in the medium and exposure time, is not necessarily the relevant measure of cytostatic action of drugs in vitro. We therefore studied absorbed doses in Chinese hamster cells. Intracellular concentration of Adriamycin is not proportional to the product of concentration in the medium and exposure time. At constant exposure time intracellular drug concentration increases proportionally to extracellular druig concentration. With increasing exposure times, however, the intracellular Adriamycin concentration did not change significantly between 2 and 4 h exposure time. Thus, the surviving fraction, which appeared to be an exponential function of exposure dose, is not a simple exponential function of absorbed dose. Fig. 8 shows the SF of Chinese hamster cells after treatment with 1 /tg/ml Adriamycin for 30, 60, 90 and 120 min (as presented in Fig. 3 ) plotted against absorbed dose, as determined by integrating the intracellular concentration curve in Fig. 6 . This survival curve is neither an exponential nor a simple power function. Intracellular dose is more meaningful conceptually but obviously not "the" biologically active dose. Interpretation of this curve is not possible without detailed knowledge of the micro-distribution of the active moiety in the various intracellular compartments and the mechanisms by which it kills mammalian cells.
Since the saturation curve of intracellular drug concentration with graded exposure times could be due to the pharmacokinetics of different compartments of uptake and binding, we studied to what extent Adriamycin could be washed out of the cells. The drug concentration after 1 h rinsing is probably the firmly bound moiety. Its concentration curve is shifted parallel to the total concentration curve. Thus, neither the bound nor the exchangeable compartments will explain the shape of the doseresponse curve of Chinese hamster cells to increasing exposure times to Adriamycin in vitro.
